180 Life Sciences Soars 50.2% on ETH Holdings, Rebranding

180 Life Sciences (ETHZilla) has seen a remarkable surge of 50.2% in pre-market trading on August 13, 2025, driven by significant developments in its cryptocurrency holdings and strategic rebranding efforts.

The company announced that it holds a substantial amount of 82,186 Ether (ETH), valued at approximately $349 million. This disclosure has sparked considerable investor interest, leading to a notable increase in stock price. The ETH holdings were acquired at an average price of $3,806.71 per token, reflecting a strategic investment in the cryptocurrency market.

In addition to its ETH holdings, 180 Life Sciences also disclosed that it has approximately $238 million in cash reserves. This financial strength has further bolstered investor confidence, contributing to the stock's upward trajectory. The company's decision to rebrand as ETHZilla Corporation underscores its commitment to leveraging blockchain technology and cryptocurrency investments to drive growth and innovation.

The surge in stock price is a testament to the company's strategic investments and rebranding efforts, positioning it as a key player in the rapidly evolving cryptocurrency landscape. Investors are closely watching 180 Life Sciences' next moves, anticipating further developments that could continue to drive its stock price higher.